Lv44
620 积分 2024-11-18 加入
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT
12小时前
已完结
Randomized, Phase III Trial of Mixed Formulation of Fosrolapitant and Palonosetron (HR20013) in Preventing Cisplatin-Based Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: PROFIT
3天前
已完结
Transforming obesity: The advancement of multi-receptor drugs
15天前
已完结
Gut hormones and bone homeostasis: potential therapeutic implications
15天前
已完结
The unexpected role of GIP in transforming obesity treatment
15天前
已完结
Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases
18天前
已完结
An overview of the safety and efficacy of LX-9211 in treating neuropathic pain conditions
18天前
已完结
A cryptic pocket in CB1 drives peripheral and functional selectivity
22天前
已关闭
Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation
23天前
已完结
Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
25天前
已完结
VX-548 in the treatment of acute pain
4个月前
已采纳
VX-548 in the treatment of acute pain
4个月前
已采纳
皖公网安备34019202002308
